Historical Valuation
Metagenomi Inc (MGX) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.80 is considered Undervalued compared with the five-year average of -1.29. The fair price of Metagenomi Inc (MGX) is between 6.66 to 9.02 according to relative valuation methord. Compared to the current price of 1.79 USD , Metagenomi Inc is Undervalued By 73.14%.
Relative Value
Fair Zone
6.66-9.02
Current Price：1.79
73.14%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Metagenomi Inc (MGX) has a current Price-to-Book (P/B) ratio of 0.35. Compared to its 3-year average P/B ratio of 0.40 , the current P/B ratio is approximately -11.15% higher. Relative to its 5-year average P/B ratio of 0.40, the current P/B ratio is about -11.15% higher. Metagenomi Inc (MGX) has a Forward Free Cash Flow (FCF) yield of approximately -147.43%. Compared to its 3-year average FCF yield of -110.05%, the current FCF yield is approximately 33.97% lower. Relative to its 5-year average FCF yield of -110.05% , the current FCF yield is about 33.97% lower.
P/B
Median3y
0.40
Median5y
0.40
FCF Yield
Median3y
-110.05
Median5y
-110.05
Competitors Valuation Multiple
AI Analysis for MGX
The average P/S ratio for MGX competitors is 39.82, providing a benchmark for relative valuation. Metagenomi Inc Corp (MGX.O) exhibits a P/S ratio of 2.80, which is -92.97% above the industry average. Given its robust revenue growth of -24.80%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for MGX
1Y
3Y
5Y
Market capitalization of MGX increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of MGX in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is MGX currently overvalued or undervalued?
Metagenomi Inc (MGX) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.80 is considered Undervalued compared with the five-year average of -1.29. The fair price of Metagenomi Inc (MGX) is between 6.66 to 9.02 according to relative valuation methord. Compared to the current price of 1.79 USD , Metagenomi Inc is Undervalued By 73.14% .
What is Metagenomi Inc (MGX) fair value?
MGX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Metagenomi Inc (MGX) is between 6.66 to 9.02 according to relative valuation methord.
How does MGX's valuation metrics compare to the industry average?
The average P/S ratio for MGX's competitors is 39.82, providing a benchmark for relative valuation. Metagenomi Inc Corp (MGX) exhibits a P/S ratio of 2.80, which is -92.97% above the industry average. Given its robust revenue growth of -24.80%, this premium appears unsustainable.
What is the current P/B ratio for Metagenomi Inc (MGX) as of Jan 10 2026?
As of Jan 10 2026, Metagenomi Inc (MGX) has a P/B ratio of 0.35. This indicates that the market values MGX at 0.35 times its book value.
What is the current FCF Yield for Metagenomi Inc (MGX) as of Jan 10 2026?
As of Jan 10 2026, Metagenomi Inc (MGX) has a FCF Yield of -147.43%. This means that for every dollar of Metagenomi Inc’s market capitalization, the company generates -147.43 cents in free cash flow.
What is the current Forward P/E ratio for Metagenomi Inc (MGX) as of Jan 10 2026?
As of Jan 10 2026, Metagenomi Inc (MGX) has a Forward P/E ratio of -0.67. This means the market is willing to pay $-0.67 for every dollar of Metagenomi Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Metagenomi Inc (MGX) as of Jan 10 2026?
As of Jan 10 2026, Metagenomi Inc (MGX) has a Forward P/S ratio of 2.80. This means the market is valuing MGX at $2.80 for every dollar of expected revenue over the next 12 months.